REFERENCES
1. Red-Horse K, Crawford Y, Shojaei F, Ferrara N. Endothelium-microenvironment interactions in the developing embryo and in the adult. Dev Cell. 2007;12:181-94.
2. Minami T, Muramatsu M, Kume T. Organ/tissue-specific vascular endothelial cell heterogeneity in health and disease. Biol Pharm Bull. 2019;42:1609-19.
3. Augustin HG, Koh GY. A systems view of the vascular endothelium in health and disease. Cell. 2024;187:4833-58.
4. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345:1247125.
5. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013;110:3507-12.
6. Naderi-Meshkin H, Cornelius VA, Eleftheriadou M, Potel KN, Setyaningsih WAW, Margariti A. Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies. Stem Cell Res Ther. 2023;14:292.
7. Wimmer RA, Leopoldi A, Aichinger M, et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019;565:505-10.
8. Payne LB, Tewari BP, Dunkenberger L, et al. Pericyte progenitor coupling to the emerging endothelium during vasculogenesis via connexin 43. Arterioscler Thromb Vasc Biol. 2022;42:e96-e114.
9. Cahill TJ, Sun X, Ravaud C, et al. Tissue-resident macrophages regulate lymphatic vessel growth and patterning in the developing heart. Development. 2021;148:dev194563.
10. Bizou M, Itier R, Majdoubi M, et al. Cardiac macrophage subsets differentially regulate lymphatic network remodeling during pressure overload. Sci Rep. 2021;11:16801.
11. Mu X, Gerhard-Herman MD, Zhang YS. Building blood vessel chips with enhanced physiological relevance. Adv Mater Technol. 2023;8:2201778.
12. Salewskij K, Penninger JM. Blood vessel organoids for development and disease. Circ Res. 2023;132:498-510.
13. Hirth E, Cao W, Peltonen M, et al. Self-assembled and perfusable microvasculature-on-chip for modeling leukocyte trafficking. Lab Chip. 2024;24:292-304.
14. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005;7:452-64.
15. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005;97:512-23.
16. Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci. 2011;14:1398-405.
17. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood. 2009;114:5091-101.
18. Jiao YC, Wang YX, Liu WZ, et al. Advances in the differentiation of pluripotent stem cells into vascular cells. World J Stem Cells. 2024;16:137-50.
19. Patsch C, Challet-Meylan L, Thoma EC, et al. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 2015;17:994-1003.
20. Orlova VV, van den Hil FE, Petrus-Reurer S, Drabsch Y, Ten Dijke P, Mummery CL. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat Protoc. 2014;9:1514-31.
21. Zhang S, Dutton JR, Su L, Zhang J, Ye L. The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells. Biomaterials. 2014;35:3786-93.
22. Aisenbrey EA, Torr E, Johnson H, Soref C, Daly W, Murphy WL. A protocol for rapid pericyte differentiation of human induced pluripotent stem cells. STAR Protoc. 2021;2:100261.
23. Kumar A, D’Souza SS, Moskvin OV, et al. Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts. Cell Rep. 2017;19:1902-16.
24. Miao Y, Pek NM, Tan C, et al. Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoids. Cell. 2025;188:4295-4313.e27.
25. Ng AHM, Khoshakhlagh P, Rojo Arias JE, et al. A comprehensive library of human transcription factors for cell fate engineering. Nat Biotechnol. 2021;39:510-9.
26. Gong L, Zhang Y, Zhu Y, et al. Rapid generation of functional vascular organoids via simultaneous transcription factor activation of endothelial and mural lineages. Cell Stem Cell. 2025;32:1200-1217.e6.
27. Zhao Y, Sun M, Zhang K, Melero-Martin JM, Wang X, Wang K. Generation of synthetic vascular organoids via orthogonal programming of human pluripotent stem cells. Cell Regen. 2026;15:23.
28. Zaret KS. Cell fate conversion: a chromatin remodeling checkpoint revealed. Cell Res. 2017;27:598-9.
29. Li F, Hu J. Direct lineage conversion with pluripotency factors: a risky detour through transient pluripotency? Genes Dis. 2015;2:286-7.
30. Giles R, Meijer EM, Maas RGC, van Dijk CGM, Verhaar MC, Cheng C. Animal-free alternatives for matrigel in human iPSC-derived blood vessel organoid culture. Sci Rep. 2025;15:36042.
31. Xu C, He S, Zhu Y, et al. Vascular organoid generation from human-induced pluripotent stem cells. J Vis Exp. 2024;214:10.3791/67125.
32. Adams WJ, Zhang Y, Cloutier J, et al. Functional vascular endothelium derived from human induced pluripotent stem cells. Stem Cell Reports. 2013;1:105-13.
34. Huang Y, Liu Z, Li M, et al. Deciphering the impact of aging on splenic endothelial cell heterogeneity and immunosenescence through single-cell RNA sequencing analysis. Immun Ageing. 2024;21:48.
35. Wang L, Xiang M, Liu Y, et al. Human induced pluripotent stem cells derived endothelial cells mimicking vascular inflammatory response under flow. Biomicrofluidics. 2016;10:014106.
36. Alcaide P. Mechanisms regulating T cell-endothelial cell interactions. Cold Spring Harb Perspect Med. 2022;12:a041170.
37. de Haan L, Suijker J, van Roey R, et al. A microfluidic 3d endothelium-on-a-chip model to study transendothelial migration of T cells in health and disease. Int J Mol Sci. 2021;22:8234.
38. Sonninen TM, Peltonen S, Kälvälä S, et al. From inserts to chips: microfluidic culture and 3D astrocyte co-culture drive functional and transcriptomic changes in hiPSC-derived endothelial cells. Fluids Barriers CNS. 2025;22:58.
39. Qi D, Wu S, Lin H, et al. Establishment of a human iPSC- and nanofiber-based microphysiological blood-brain barrier system. ACS Appl Mater Interfaces. 2018;10:21825-35.
40. Han Y, Guo L, Wang M, et al. Bioengineering an improved three-dimensional vascularized co-culture model for studying neuron-microglia interactions. Bioact Mater. 2025;54:813-28.
41. Kong SY, Kim DH. Human iPSC-derived vascularized organoids: strategy-based insights from 2D endothelial cells to 3D blood vessel organoids. Biofabrication. 2026.
42. Gordiichuk P, Bai J, Bolonduro OA, et al. Development of a human 3D immune-competent neurovascular model enabling time-resolved monitoring of neuroinflammatory dynamics and neuroimmune interactions. Adv Sci. 2026;13:e75461.
43. Singh R, Mori N, Kida YS. Methodological innovations in perfusable vascular networks: Advancing high-density tissue models. Regen Ther. 2026;32:101109.
45. Sweet DR, Lam C, Jain MK. Evolutionary protection of krüppel-like factors 2 and 4 in the development of the mature hemovascular system. Front Cardiovasc Med. 2021;8:645719.
46. Pasqualini FS, Emmert MY, Parker KK, Hoerstrup SP. Organ chips: quality assurance systems in regenerative medicine. Clin Pharmacol Ther. 2017;101:31-4.
47. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678-89.
48. Cucullo L, Marchi N, Hossain M, Janigro D. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow Metab. 2011;31:767-77.
49. Eltaibany AA, McGovern K, Nzou G, Porada D, Seeds MC, Atala A. Modeling neuroimmunological interactions at the blood-brain barrier using in vitro 3D human organoids: inflammation and ischemia-reperfusion injury. Cells. 2026;15:1173.
50. Gu L, Mao X, Tian C, et al. Engineering blood-brain barrier microphysiological systems to model Alzheimer’s disease monocyte penetration and infiltration. Biomater Sci. 2025;13:3650-61.
51. Birtele M, Lancaster M, Quadrato G. Modelling human brain development and disease with organoids. Nat Rev Mol Cell Biol. 2025;26:389-412.
52. Sontheimer-Phelps A, Hassell BA, Ingber DE. Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019;19:65-81.
53. Liu H, Noguera-Ortega E, Dong X, et al. A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors. Nat Biotechnol. 2026;44:959-75.
54. Li K, Liu C, Sui X, et al. An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer. Cell Stem Cell. 2025;32:1218-1234.e7.
55. Baisiwala S, Fazzari E, Li MX, et al. A human tumor-immune organoid model of glioblastoma. Cell Rep. 2026;45:116790.
56. Cai L, Xiao Y, Xie F, Yang Z. Tumor organoid-immune cell co-culture systems for precision oncology. Front Cell Dev Biol. 2026;14:1865487.
57. Kawakami E, Saiki N, Yoneyama Y, et al. Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19. Cell Stem Cell. 2023;30:1315-1330.e10.
58. Rauti R, Navok S, Biran D, et al. Insight on bacterial newborn meningitis using a neurovascular-unit-on-a-chip. Microbiol Spectr. 2023;11:e0123323.
59. Bennett AB, Lanser DM, Vu K, Sahoo AR, Buck M, Gelli A. Macropinocytosis mediates neurotropism of cryptococcus neoformans in a human organoid model of the blood-brain barrier. Commun Biol. 2026.
60. Boghdeh-Olson NA, Barrera MD, Britt CM, et al. Application of a blood-brain barrier organ-on-a-chip model for assessment of countermeasure efficiency against eastern equine encephalitis virus. Viruses. 2026;18:548.
61. Chen YW, Chiang HJ, Liu KT, et al. Integration of biomimetic organoid-on-chip and 2D models advances the mechanistic understanding of STEAP3-mediated regulation in intestinal viral infection. Sci Rep. 2025;15:30582.
62. Wang Y, Guo Y, Wang P, et al. An engineered human placental organoid microphysiological system in a vascular niche to model viral infection. Commun Biol. 2025;8:669.
63. Koh H, Kang W, Mao YY, et al. Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT). Cell Biosci. 2024;14:65.
64. Wang Z, Yin J, Chao W, Zhang X. Inducing mononuclear cells of patients with CADASIL to construct a CSVD disease model. Eur J Med Res. 2025;30:227.
65. Kong D, Ryu JC, Shin N, et al. In vitro modeling of atherosclerosis using iPSC-derived blood vessel organoids. Adv Healthc Mater. 2025;14:e2400919.
66. Nguyen V, Harper A, Azuero M, et al. Vascular organoids derived from capillary malformation-induced pluripotent stem cells exhibit disease-relevant phenotypes. Stem Cell Rev Rep. 2026;22:668-75.
67. He S, Zhang J, Wang X, et al. Organoid modeling and single-cell profiling reveal smooth muscle cell migration in moyamoya disease. Commun Biol. 2026;9:198.
68. Wu M, Li S, Liu W, Guo Z, Guo Z, Zhang D. RNF213 deficiency in human iPSC-derived vascular organoids captures key feature of moyamoya disease vasculopathy. Microvasc Res. 2026;167:104979.
69. Sun X, Che S, Wang H, et al. Vascular organoid model of hutchinson-gilford progeria syndrome uncovers repression of the SRF pathway in premature aging. Dev Cell. 2026;61:505-517.e7.
70. Naderi-Meshkin H, Wahyu Setyaningsih WA, Yacoub A, et al. Unveiling impaired vascular function and cellular heterogeneity in diabetic donor-derived vascular organoids. Stem Cells. 2024;42:791-808.
71. Su L, Kong X, Loo SJ, et al. Diabetic endothelial cells differentiated from patient iPSCs show dysregulated glycine homeostasis and senescence associated phenotypes. Front Cell Dev Biol. 2021;9:667252.
72. Su L, Kong X, Loo S, et al. Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells. Stem Cell Res Ther. 2022;13:13.
73. Ji Y, Chen X, Wang Z, et al. Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery. Mol Psychiatry. 2025;30:4558-75.
74. Uzoechi SC, Johnson-Campbell C, Badeaux CJ, Kwak SS, Kim DY, Yun Y. Recapitulating Alzheimer’s disease pathophysiology with a microfluidic neurospheroid-grafted endothelial barrier model. Mol Brain. 2026;19:25.
75. Aleman J, Vernetti L, Schurdak ME, et al. Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression. BMC Biotechnol. 2026;26:70.
76. Kota VG, Yi JLJ, Zhang Z, Yooyuen A, Yu H, Leo HL. Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation. Atherosclerosis. 2026;417:120762.
77. Ingber DE. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022;23:467-91.
78. Juraski AC, Sharma S, Sparanese S, et al. 3D bioprinting for organ and organoid models and disease modeling. Expert Opin Drug Discov. 2023;18:1043-59.
79. Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 2015;73:254-71.
80. Chaudhuri O, Gu L, Klumpers D, et al. Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat Mater. 2016;15:326-34.
81. Kosyakova N, Kao DD, Figetakis M, et al. Differential functional roles of fibroblasts and pericytes in the formation of tissue-engineered microvascular networks in vitro. NPJ Regen Med. 2020;5:1.
82. Zheng F, Chen Y, Xue G, et al. Differentiation of arterioles and capillaries in human blood vessel organoids with decellularized splenic matrix. Bioact Mater. 2026;64:731-43.
83. Mazari-Arrighi E, Boyreau A, Chaillot L, et al. A versatile microfluidic extrusion-based hydrogel platform for self-organization and long-term maintenance of engineered 3D lymphatic endothelium. Adv Healthc Mater. 2026;15:e71307.
84. Jung O, Tung YT, Sim E, et al. Development of human-derived, three-dimensional respiratory epithelial tissue constructs with perfusable microvasculature on a high-throughput microfluidics screening platform. Biofabrication. 2022;14:025012.
85. Luu RJ, Hoefler BC, Gard AL, et al. Fibroblast activation in response to TGFβ1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform. Front Mol Biosci. 2023;10:1160851.
86. Hu SY, Xu XY, Xue CD, Qin KR. A microfluidic system for modeling endothelial dysfunction under combined physiological pulsatile shear stress and oscillatory hyperglycemia. J Vis Exp. 2026;231.
87. Zhu L, Zhao W, Shen M, et al. Human BBB-brain organoid on a millifluidic plate for modeling brain parenchymal pathology-induced barrier dysfunction. J Adv Res. 2026:S2090-1232(26)00506.
88. Lombardo JA, Aliaghaei M, Nguyen QH, Kessenbrock K, Haun JB. Microfluidic platform accelerates tissue processing into single cells for molecular analysis and primary culture models. Nat Commun. 2021;12:2858.
89. Wills QF, Mellado-Gomez E, Nolan R, et al. The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-Seq. BMC Genomics. 2017;18:53.
90. Jones CFE, Di Cio S, Connelly JT, Gautrot JE. Design of an integrated microvascularized human skin-on-a-chip tissue equivalent model. Front Bioeng Biotechnol. 2022;10:915702.
91. Novak R, Ingram M, Marquez S, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407-20.
92. Quintard C, Tubbs E, Jonsson G, et al. A microfluidic platform integrating functional vascularized organoids-on-chip. Nat Commun. 2024;15:1452.
93. Jun Y, Nguyen-Ngoc KV, Sai S, et al. Engineered vasculature induces functional maturation of pluripotent stem cell-derived islet organoids. Dev Cell. 2025;60:2455-2469.e7.
94. Marder M, Remmert C, Perschel JA, et al. Stem cell-derived vessels-on-chip for cardiovascular disease modeling. Cell Rep. 2024;43:114008.
95. Acun A, Zorlutuna P. CRISPR/Cas9 edited induced pluripotent stem cell-based vascular tissues to model aging and disease-dependent impairment. Tissue Eng Part A. 2019;25:759-72.
96. Skowronek D, Pilz RA, Saenko VV, et al. High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins. Angiogenesis. 2025;28:32.
97. Guo H, Yu X, Liu Y, et al. SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant. Sci Transl Med. 2023;15:eabp9952.
98. Sarmah H, Iannello G, Wantroba R, et al. Protocol for clonal isolation of gene-edited hiPSCs using droplet and microfluidic sorting. STAR Protoc. 2026;7:104518.
99. Nikolova MT, He Z, Seimiya M, et al. Fate and state transitions during human blood vessel organoid development. Cell. 2025;188:3329-3348.e31.
100. Korbmacher F, Long RKM, Fleckenstein H, et al. ETS-guided iPSC-endothelial models recapitulate malaria pathogenesis. EMBO Mol Med. 2026;18:3389-418.
101. Shen AN, Matazel KS, Gill WD, Ewart L, Daughters RS, Rosas-Hernandez H. Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model. Fluids Barriers CNS. 2026;23:1.
102. Guelfi S, Gopalan KS, Maene P, et al. Murine vascular organoids are responsive and adaptable 3D systems with cellular heterogeneity and dynamic plasticity. Sci Adv. 2025;11:eady4738.
103. Kim DH, Lee Y, Kim MJ, Lee AC, Kwon S, Kang KS. Leveraging IGF signaling to improve the spatial organization and regenerative potential of iPSC-derived vascularized liver organoids. Sci Adv. 2026;12:eaea3814.
104. Zhang X, Jeya Vandana J, Greenspun B, Chen S. Dissecting human organ development using spatial technologies. Dev Cell. 2026;61:1363-91.
105. Marx U, Akabane T, Andersson TB, et al. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. ALTEX. 2020;37:365-94.
106. Helle E, Ampuja M, Dainis A, et al. HiPS-endothelial cells acquire cardiac endothelial phenotype in co-culture with hiPS-cardiomyocytes. Front Cell Dev Biol. 2021;9:715093.
107. Huang NF, Chaudhuri O, Cahan P, et al. Multi-scale cellular engineering: from molecules to organ-on-a-chip. APL Bioeng. 2020;4:010906.
108. Su L, Kong X, Lim S, et al. The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathways. Stem Cell Res Ther. 2018;9:313.
109. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593-604.
110. Miller JS. The billion cell construct: will three-dimensional printing get us there? PLoS Biol. 2014;12:e1001882.
111. Smith Q, Gerecht S. Going with the flow: microfluidic platforms in vascular tissue engineering. Curr Opin Chem Eng. 2014;3:42-50.
112. Blakely AM, Manning KL, Tripathi A, Morgan JR. Bio-pick, place, and perfuse: a new instrument for three-dimensional tissue engineering. Tissue Eng Part C Methods. 2015;21:737-46.
113. Ronaldson-Bouchard K, Teles D, Yeager K, et al. A multi-organ chip with matured tissue niches linked by vascular flow. Nat Biomed Eng. 2022;6:351-71.
114. Zhang YS, Aleman J, Shin SR, et al. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc Natl Acad Sci U S A. 2017;114:E2293-302.
115. Petrus-Reurer S, Romano M, Howlett S, Jones JL, Lombardi G, Saeb-Parsy K. Immunological considerations and challenges for regenerative cellular therapies. Commun Biol. 2021;4:798.
116. Trounson A, DeWitt ND. Pluripotent stem cells progressing to the clinic. Nat Rev Mol Cell Biol. 2016;17:194-200.
117. Deuse T, Hu X, Gravina A, et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat Biotechnol. 2019;37:252-8.
118. Hu X, White K, Olroyd AG, et al. Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. Nat Biotechnol. 2024;42:413-23.
119. Vegas AJ, Veiseh O, Gürtler M, et al. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med. 2016;22:306-11.
120. Raheem A, Khan I, Ahmad I, et al. The emerging role of tissue regulatory T cells in tissue repair and regeneration. Front Immunol. 2025;16:1640113.
121. Buchrieser J, James W, Moore MD. Human induced pluripotent stem cell-derived macrophages share ontogeny with MYB-independent tissue-resident macrophages. Stem Cell Reports. 2017;8:334-45.
122. Lohasz C, Häfeli T, Hasanova D, et al. A microfluidic platform for the co-culturing of microtissues with continuously recirculating suspension cells. Microsyst Nanoeng. 2025;11:184.
123. Battumur E, Clegg JR, Acar H. Exploring macrophage polarization: biological insights, key laboratory techniques and research perspectives. Front Immunol. 2026;17:1837287.
124. Lee CZW, Tasnim F, Huang X, et al. Direct contact between iPSC-derived macrophages and hepatocytes drives reciprocal acquisition of Kupffer cell identity and hepatocyte maturation. Elife. 2026;14:RP108938.
125. Klepikova A, Nenasheva T, Sheveleva O, et al. iPSC-derived macrophages: the differentiation protocol affects cell immune characteristics and differentiation trajectories. Int J Mol Sci. 2022;23:16087.
126. Chau CW, To A, Au-Yeung RKH, et al. SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids. Sci Rep. 2024;14:8781.
127. Badai J, Bu Q, Zhang L. Review of artificial intelligence applications and algorithms for brain organoid research. Interdiscip Sci. 2020;12:383-94.
128. Borten MA, Bajikar SS, Sasaki N, Clevers H, Janes KA. Automated brightfield morphometry of 3D organoid populations by OrganoSeg. Sci Rep. 2018;8:5319.
129. Yun E, Kim J, Jeong D. Lightweight deep learning model for classification of normal and abnormal vasculature in organoid Images. Sensors. 2025;26:112.
